Lysyl oxidase-like 2 (LOXL2), an enzyme promoting collagen cross-linking, is upregulated in the livers of animals with fibrosis (70) and of diabetic patients with NAFLD (71) and is essential in hepatic fibrogenesis (72). Here, LOXL2 is linked to metabolic dysfunction-associated steatotic liver disease.